Offer new treatments only as part of post-market trials until data on meaningful outcomes are available, says Ben Goldacre to BMJ

Watch the video from the BMJ channel below:

Comments

Popular posts from this blog

"Don't go so fast: we're in a hurry!"

The freak accident that changed Charles Krauthammer's life